AlzeCure Pharma to present at Stora Aktiedagarna in Stockholm on March 11

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company’s CEO Martin Jönsson will present at Stora Aktiedagarna in Stockholm, Sweden, hosted by Aktiespararna, at 08:50 CET on March 11.

In his presentation, Martin Jönsson will provide an update on the company’s recent developments and strategic plans going forward, with a focus on the company’s project portfolio and its drug candidates from the research platforms NeuroRestore®, Alzstatin® and Painless. The presentation will be followed by a Q&A led by Aktiespararna’s moderator.

The live broadcast is available via the following link: https://invitepeople.com/public/events/ad0e0ffac7/pages/af1743879f

The presentation will also be available on the company's website afterwards: https://www.alzecurepharma.se/en/presentations-and-interviews/

For more information about the event and to register to attend the Birger Jarl Conference in Stockholm, please see here: https://www.aktiespararna.se/aktiviteter/stora-aktiedagarna-i-stockholm-67703

Event time: March 10, 08:00 CET – March 11, 20:00 CET
Presentation time: March 11, 08:50 CET
Venue: Birger Jarl Konferens, Birger Jarlsgatan 61 A, Stockholm, Sweden